News

Viking Holdings (NYSE:VIK) recently completed a significant Follow-on Equity Offering, raising $1.35 billion by issuing over 30 million shares at $44.20 each. This capital-raising effort may have ...
Archaeologist Greer Jarrett at Lund University in Sweden has been sailing in the footsteps of Vikings for three years. He can now show that the Vikings sailed farther away from Scandinavia and ...
The Viking-era gravesite was discovered on the outskirts of Linköping, a city in southern Sweden, in fall 2022. Arkeologerna. Archaeologists soon found that the person in the grave had been ...
Viking unveils latest cruise ship for the Nile River. A new ship is coming to the Nile River – here’s everything you need to know. Marc Shoffman. Monday 12 May 2025 11:52 BST. Comments.
Viking's leading drug candidate could be a blockbuster in the weight loss market, which experts believe could grow to $150 billion over the coming years.
Viking Therapeutics (VKTX-0.57%) stands out as another potential acquisition target for Pfizer. The company expects to begin phase 3 testing of a subcutaneous version of GLP-1/GIP receptor dual ...
The flagship product in this collection is the GRXC3 Berserker Viking GR1 backpack — a reimagined GoRuck staple. GoRuck Third time’s a charm. As mentioned, this isn’t the first time GoRuck and ...
To help you wring the event for all its worth, we've put together a list below of all the Monopoly Go Viking Voyage rewards and how you can claim every single one. To see this content please ...
IT seems there’s some truth in the myths after all. Archaeologists in Denmark have found the burial site of a Viking ‘berserker’ warrior — complete with an oversized battle axe.
Viking® (www.viking.com) (NYSE: VIK) and Fincantieri today announced details of the Viking Libra, the world’s first hydrogen-powered cruise ship, capable of ...
An unidentified man found the armlet in a wetland last fall. Kalmar County Administrative Board. Last fall, a Swedish man spotted something in a marsh on Oland, Sweden’s second-largest island.
Viking Therapeutics (VKTX-9.04%) soared into the spotlight about a year ago when it delivered promising data on a drug candidate that aims to compete in an area of very high demand: weight loss.